Sun Pharmaceutical Industries
Cluster: Ugly Duckling
Recommendation: Buy
Caraco comes under USFDA scanner
The US Food and Drug Administration (USFDA) has issued a warning letter to Sun Pharmaceuticals’ US based subsidiary Caraco Pharmaceutical Laboratories (Caraco), citing lack of adequate quality control procedures at Caraco’s Detroit-based manufacturing facility. The letter was issued as a follow-up to the last USFDA inspection of the company’s manufacturing facility in Detroit, Michigan. After the inspection, which was initiated in May 2008, a Form 483 notice, listing the issues, had been issued to Caraco.
Related posts:
- Multibagger – Ranbaxy Laboratories – technical analysis- 06 November 2008
- Multibagger – Aditya Birla Nuvo – technical analysis- 06 November 2008
- Multibagger – Kirloskar Brothers Limited (KBL) – technical analysis- 19 November 2008
- Multibagger – Deepak Fertilisers & Petrochemicals Corporation – technical analysis- 06 November 2008
- Multibagger – PRAJ INDUSTRIES – technical analysis- 10 October 2008
